Saudi Arabia Distribution Deal Secured for Sky Premium Life Supplements
Cosmos Health enters Saudi Arabia through an exclusive Innova Healthcare deal, securing an initial order of 126,000 Sky Premium Life supplement units.... Read more.
Pancreatic Cyst Study Estimates Cancer Risk to Support Early Detection
Mayo Clinic researchers estimate three-year cancer risk in patients with pancreatic cysts, offering insights for surveillance, surgery and early detection.... Read more.
Dubai Ruler to Fund Treatment for Jordanian Girl with Spinal Muscular Atrophy
Dubai Ruler to fund treatment for 1-year-old Jordanian girl Katya Abu Al-Saud, who has spinal muscular atrophy and requires urgent gene therapy.... Read more.
Saudi Arabia to Introduce Health Insurance Product Without Outpatient Pre-Approvals
Saudi Arabia will introduce a health insurance product without pre-approval requests for outpatient services from November 1, 2026.... Read more.
WHO and Africa CDC Welcome Ebola Vaccine Allocation for DRC Outbreak
WHO and Africa CDC welcome 70,000 Ebola vaccine doses allocated to the DRC, including vaccines for frontline workers and a Phase 3 clinical trial.... Read more.
Strengthening Humanitarian and Emergency Healthcare Response
Aspen Medical strengthens humanitarian and emergency response capabilities, delivering rapid medical support during conflicts, disasters and health emergencies.... Read more.
WHO Launches Free Online Course on Safe Health-Care Waste Management
WHO and UNICEF launch a free online course to help health-care facilities improve safe, sustainable waste management and environmental protection.... Read more.
DUPHAT 2026 to Highlight Dubai’s Growing Role in Global Pharmaceuticals
DUPHAT 2026 will bring 25,000 visitors and 1,100 brands to Dubai, highlighting pharmaceutical innovation, manufacturing and healthcare partnerships.... Read more.
Partnership Expands CPD Access for Healthcare Professionals Across GCC
TrueProfile.io partners with MediLearning to offer 70+ DHA-accredited CPD/CME courses to healthcare professionals across the GCC.... Read more.
Personalized mRNA Therapy Shows Positive Phase 3 Results in Melanoma
Merck and Moderna report positive Phase 3 results for their personalized mRNA therapy combined with pembrolizumab in high-risk melanoma.... Read more.
